In the mRNA expression profiles analysed using the GEPIA Platform, PRRX1 and TOP2A were highly expressed in glioblastoma and pancreatic cancer as well as MPNST (Fig. 1a and Fig. S7A). This evidence concerns the gene PRRX1 and familial pancreatic carcinoma.